{
    "Trade/Device Name(s)": [
        "RapidFRET Oral Fluid Assay for Methamphetamine",
        "RapidFRET Oral Fluid Methamphetamine Calibrators",
        "RapidFRET Oral Fluid Methamphetamine Controls"
    ],
    "Submitter Information": "Biophor Diagnostics, Inc.",
    "510(k) Number": "K142293",
    "Predicate Device Reference 510(k) Number(s)": [
        "K131652"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LAF",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "September 11, 2015",
    "Summary Letter Received Date": "September 14, 2015",
    "Submission Date": "September 11, 2015",
    "Regulation Number(s)": [
        "21CFR862.3610",
        "21CFR862.3200",
        "21CFR862.3280"
    ],
    "Regulation Name(s)": [
        "Methamphetamine test system",
        "Drug Specific Calibrator",
        "Drug Specific Control Materials"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Methamphetamine"
    ],
    "Specimen Type(s)": [
        "Oral fluid"
    ],
    "Specimen Container(s)": [
        "RapidEASE Oral Fluid Collector",
        "Glass sample tube with inert screw cap"
    ],
    "Instrument(s)/Platform(s)": [
        "RapidFRET Integrated Workstation"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous time-resolved fluorescence assay",
        "Competitive immunoassay",
        "Fluorescence resonance energy transfer (FRET)"
    ],
    "Methodologies": [
        "Competitive homogeneous immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Collector"
    ],
    "Document Summary": "FDA 510(k) summary for RapidFRET Oral Fluid Assay for Methamphetamine and associated calibrators and controls using FRET-based competitive immunoassay on oral fluid",
    "Indications for Use Summary": "Qualitative screening for methamphetamine at 50 ng/mL in neat oral fluid samples collected with RapidEASE Oral Fluid Collector, for prescription use in central laboratories; preliminary results require confirmation by GC/MS or LC/MS/MS.",
    "fda_folder": "Toxicology"
}